MOLCURE will exhibit at BioJapan 2025, which will be held at PACIFICO Yokohama from October 8th (Wed) to October 10th (Fri), 2025 (Location: BioCommunity-Startup area, Booth A-33). On October 9, from 15:00 to 16:00, our CEO and CSO, Dr. Tamaki, will speak in the in-booth ‘Startup Pitch’ session to introduce our AI drug discovery platform, which integrates our proprietary antibody-specific large-language model with wet-lab experiments.

We look forward to welcoming visitors to our booth and the pitch presentation to explore how our cutting-edge AI technologies accelerate de novo discovery and optimization of antibody and peptide drug candidates.